$1.32
Price
$554M
Market Cap
—
P/E Ratio
-5.4
Forward P/E
$-0.19
EPS (TTM)
—
Dividend Yield
$116M
Cash
$108M
Total Debt
418M
Shares Out
$0.28
$1.83
52-Week Range
Institutional Ownership of ALEXION PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for ALEXION PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2021-Q3 | |||||
| SELL | EXIT | — | — | $3.94 | |
| 2021-Q2 | |||||
| SELL | -18.8% | 3.4K | $630000 | $4.80 | |
| 2021-Q1 | |||||
| BUY | +4.3% | 4.2K | $646000 | $7.37 | |
| 2020-Q4 | |||||
| SELL | -17.8% | 4.0K | $633000 | $1.49 | |
| 2020-Q3 | |||||
| SELL | -17.7% | 4.9K | $563000 | $1.81 | |
| 2020-Q2 | |||||
| SELL | -21.4% | 6.0K | $672000 | $1.94 | |
| 2020-Q1 | |||||
| SELL | EXIT | — | — | $2.92 | |
| BUY | NEW | 7.6K | $684000 | $2.92 | |
| 2019-Q4 | |||||
| SELL | EXIT | — | — | $3.71 | |
| SELL | -13.5% | 388.4K | $42M | $3.71 | |
| 2019-Q3 | |||||
| SELL | -2.6% | 1.3M | $132M | $2.20 | |
| 2019-Q2 | |||||
| BUY | +16.9% | 1.4M | $181M | $5.92 | |
| BUY | +0.2% | 448.8K | $59M | $5.92 | |
| 2019-Q1 | |||||
| BUY | +13.7% | 1.2M | $160M | $5.66 | |
| SELL | -0.1% | 447.7K | $61M | $5.66 | |
| 2018-Q4 | |||||
| SELL | -12.8% | 1.0M | $101M | $8.22 | |
| SELL | -0.1% | 448.1K | $44M | $8.22 | |
| 2018-Q3 | |||||
| BUY | +10.2% | 1.2M | $166M | $11.10 | |
| BUY | +1.5% | 448.8K | $62M | $11.10 | |
| 2018-Q2 | |||||
| BUY | NEW | 1.1M | $135M | $9.59 | |
| BUY | +5.0% | 442.3K | $55M | $9.59 | |
| 2018-Q1 | |||||
| SELL | -3.6% | 421.1K | $47M | $8.85 | |
Insider Trading for ALEXION PHARMACEUTICALS INC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.